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Abstract
Background: Geminiviruses cause damaging diseases in several important crop species. However, limited progress
has been made in developing crop varieties resistant to these highly diverse DNA viruses. Recently, the bacterial
CRISPR/Cas9 system has been transferred to plants to target and confer immunity to geminiviruses. In this study,
we use CRISPR-Cas9 interference in the staple food crop cassava with the aim of engineering resistance to African
cassava mosaic virus, a member of a widespread and important family (Geminiviridae) of plant-pathogenic DNA
viruses.
Results: Our results show that the CRISPR system fails to confer effective resistance to the virus during glasshouse
inoculations. Further, we find that between 33 and 48% of edited virus genomes evolve a conserved single-
nucleotide mutation that confers resistance to CRISPR-Cas9 cleavage. We also find that in the model plant
Nicotiana benthamiana the replication of the novel, mutant virus is dependent on the presence of the wild-
type virus.
Conclusions: Our study highlights the risks associated with CRISPR-Cas9 virus immunity in eukaryotes given
that the mutagenic nature of the system generates viral escapes in a short time period. Our in-depth analysis
of virus populations also represents a template for future studies analyzing virus escape from anti-viral CRISPR
transgenics. This is especially important for informing regulation of such actively mutagenic applications of
CRISPR-Cas9 technology in agriculture.
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Background
The bacterial CRISPR-Cas9 (clustered, regularly inter-
spaced short palindromic repeats-CRISPR associated 9)
gene editing system can be used to engineer resistance to
DNA viruses through direct cleavage of the virus genome.
Unlike conventional gene editing using CRISPR-Cas9, en-
gineering virus interference requires constitutive and per-
manent expression of the ribonucleoprotein complex in
the host. For example, the CRISPR/Cas9 system has been
used to engineer immunity to latent HIV-1 proviruses,
hepatitis B viruses, herpes simplex virus, and the human
papillomavirus in mammalian cell lines [1]. CRISPR-Cas9
has also been used in the model plants Arabidopsis thali-
ana and Nicotiana benthamiana to engineer resistance to
single-stranded DNA (ssDNA) geminiviruses [2–4] and a
double-stranded DNA (dsDNA) pararetrovirus [5]. How-
ever, the degree to which using CRISPR-Cas9 interference
to engineer virus-resistance results in the evolution of re-
sistant viruses is unknown. One concern (which has previ-
ously been highlighted [6]) might be that planting
transgenic, virus-resistant CRISPR-Cas9 plants in the field
will impose a selection pressure on viruses, while simul-
taneously providing viruses with a mechanism (via
Cas9-induced mutations) to escape resistance. Transient
studies using Tobacco rattle virus-based delivery of the
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CRISPR-Cas9 and gRNA in Nicotiana benthamiana sug-
gest that geminiviruses can be repaired by non-homolo-
gous end joining (NHEJ) at the target site [7].
Cassava is a tropical staple food crop consumed by
more than a billion people. Cassava production in Africa
and South Asia can be decimated by cassava mosaic
geminiviruses [8]. Biotechnology has proven effective for
engineering cassava mosaic virus resistance by using
plant endogenous RNA interference (RNAi) pathways to
limit the expression of virus genes [9]. However, the fact
that plant viruses have developed effective suppressors
of RNAi [10], as well as the limited success of
RNAi-mediated geminivirus resistance [11], suggests
that newer methods of engineering resistance are
needed. Using orthogonal systems (i.e., independently
evolved systems) like CRISPR-Cas9 to which plant vi-
ruses are unlikely to have developed escape mechanisms
hence appears particularly attractive. We applied
CRISPR-Cas9 to engineer resistance to geminiviruses,
specifically the African cassava mosaic virus (ACMV)
(Begomovirus; Geminiviridae) in cassava and investi-
gated the impact of engineering resistance on gemini-
virus evolution. CRISPR-Cas9 transgenic plants failed to
demonstrate effective geminivirus resistance, and we
found that the use of CRISPR-Cas9 led to emergence of
a novel, conserved mutant virus that cannot be cleaved
by CRISPR-Cas9. We urge caution in the application of
CRISPR-Cas9 for virus resistance in plants, both in
glasshouse and field settings, to avoid inducing the evo-
lution of resistant viruses.
Results
We designed a set of single-guide RNAs (sgRNAs) using
a custom algorithm that combines knowledge about po-
tential off-target effects with published software predict-
ing sgRNA template-cleaving efficiency [12]. We chose
sgRNA1, which targets both the viral AC2 gene coding
for the multifunctional TrAP protein involved in gene
activation, virus pathogenicity, and suppression of gene
silencing, and the AC3 gene coding for the REn protein
involved in replication enhancement [13] (Fig. 1a, b).
Selected independent transgenic cassava lines (7 Cas9
+sgRNA1, 2 control Cas9-only lines, and wild-type
controls (WT)) were tested for transgene expression
in tissue culture (Fig. 1c, d) and for virus resistance
in the greenhouse using an infectious clone of ACMV
that was introduced using Agrobacterium tumefaciens
[9, 14]. No significant differences in disease incidence,
symptom severity, or virus titres were found between
test and control cassava lines (Table 1) (Fig. 2a–c).
This was verified by an additional infection experi-
ment in a subset of lines to account for infection
variability (Additional file 1: Table S1).
In order to better understand why we could not detect
resistance, we sequenced full-length viral amplicons
from pooled infected samples at 3 and 8 weeks post
infection (wpi) using single-molecule real-time (SMRT)
sequencing with a minimum depth of 100 full-length,
high-quality virus genomes per plant (Fig. 3a,
Additional file 1: Figure S1). We chose to sequence the
whole viral genome in order to check Cas9+sgRNA1-
mediated editing of the targeted viral sequences as well
as any other targets. A total of 4942 full-length virus
genome sequences were analyzed by alignment against
the intact wild-type ACMV genome sequence. We de-
tected CRISPR-edited virus sequences in 3 Cas9
+sgRNA1 lines at 8 wpi, with line 118 having the highest
proportion of edited virus sequences (11%) (Fig. 3a,
Fig. 2d,e). We analyzed the AC2 and AC3 genes in depth
because these were meant to be edited in Cas9+sgRNA1
lines (Additional file 1: Figures S2 and S3). We found
that control lines (WT and Cas9) and 5 of 7 Cas9
+sgRNA1 lines had similar proportions of substitution
[~ 3%] and indel [~ 3%] events. In Cas9+sgRNA1 line
118, which had the highest proportion of editing events
at 11%, there were more indels [14%] than substitutions
[3%] (Additional file 1: Figure S2). We analyzed the
predicted AC2 and AC3 proteins in all sequenced
viruses from all of the cassava lines (density plots,
Additional file 1: Figures S2 and S3). These data indicate
that the Cas9+sgRNA1 118 line (and to a lesser extent
lines 130 and 139) contains viruses with the desired
edits, where the AC2 and AC3 open reading frames stop
prematurely at the sgRNA target site. We also detected
indels that were present in viruses infecting all plants in-
cluding controls (minor peaks, Additional file 1: Figure
S2 and S3, and mismatches, Fig. 3a and Additional file 1:
Figure S8). These mutations are likely to represent nat-
urally occurring viral variants in our experiment.
While studying the CRISPR-Cas9 caused amino acid
substitutions in our entire dataset, we identified an
abundant single-nucleotide insertion in the AC2 open
reading frame (Fig. 3b–e). Interestingly, this conserved
mutation was found in three independent Cas9+sgRNA1
lines (but not in any of our three control lines). In each
of these lines, this virus variant (named ACMV-AC2
H54Q) comprised between 33 and 48% of all mutant vi-
ruses per line, which might indicate selection for this
conserved mutation (Fig. 1c). In ACMV-AC2 H54Q, the
single-nucleotide “T” insertion (Fig. 3d) results in a
H54Q substitution in the AC2 gene and production of a
premature stop codon, reducing the length of the AC2
protein from 136AA to 62AA. However, this mutation
also creates a new ORF, which might code for the
missing AC2 residues. Thus, in this viral variant
(Additional file 1: Data S1), the Cas9-mediated edit at
the target site generates two distinct translational units
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for AC2 (Additional file 1: Figure S2f ). Interestingly, the
single “T” insertion in ACMV-AC2 H54Q is in the
sgRNA seed sequence. This means that the insertion
that is selected for during editing makes ACMV-AC2
H54Q resistant to further cleavage using sgRNA1, as val-
idated using an in vitro cleavage assay (Additional file 1:
Figure S4).
In order to study if the ACMV-AC2 H54Q virus vari-
ant is capable of independent replication, we generated
an infectious agroclone of the mutant virus and inocu-
lated the model plant, Nicotiana benthamiana. N.
benthamiana plants were agro-inoculated (through leaf
infiltration) with ACMV-AC2 H54Q, ACMV-WT, and
both ACMV AC2 H54Q and ACMV-WT virus clones
along with negative controls (mock infiltration, as well
as the wild-type viral DNA A alone). Plants inoculated
with only ACMV-AC2 H54Q (as well as control plants)
failed to develop foliar disease symptoms over 4 weeks.
Plants co-inoculated with ACMV-AC2 H54Q and the
WT virus developed severe symptoms, similar to plants
inoculated with the WT virus only. We next
deep-sequenced full-length viral DNA from new leaves
Fig. 1 sgRNA design and expression profiling of CRISPR/Cas9 transgenics. a Low off-target sgRNAs targeting the DNA A of the African cassava
mosaic virus and in silico predicted efficiency score (max. efficiency= 1). b In vitro cleavage assay for testing the effectiveness of six different sgRNAs
against the viral template. c, d Reverse transcription-quantitative PCR (RT-qPCR) analysis of Cas9 and sgRNA transgene expression respectively. Three
independent plants per line were tested
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emergent post inoculation (i.e., leaves that could only
contain systemically infecting viruses) in order to test if
the ACMV-AC2 H54Q virus could replicate in the symp-
tomatic plants infected with both the WT and mutant
clones. Deep sequencing revealed that the ACMV-AC2
H54Q virus was only detectable in new leaves of plants
co-inoculated with mutant and wild-type virus, albeit at
lower frequencies of 0.05% compared to ~ 1–5% in the
cassava CRISPR transgenics (Additional file 1: Table S2).
Discussion
In our experiment, CRISPR-Cas9-mediated interference
of ACMV in cassava transgenic lines resulted in selec-
tion for a conserved, abundant, cleavage-resistant mu-
tant virus among the edited virus genomes. We did not
observe a clear disease-resistance phenotype associated
with the implementation of a CRISPR-Cas9 sgRNA1-
virus interference system. Our deep sequencing results
also show that the efficiency of CRISPR-mediated virus
cleavage was outstripped by the speed of virus replica-
tion and that this, in addition to DNA repair of cleaved
viruses, resulted in the lack of resistance.
Bacteria and archaea use the CRISPR system to defend
against viruses and plasmids, but DNA repair mechanisms
differ substantially in bacteria and archaea compared with
eukaryotes. Most bacteria lack non-homologous end
joining (NHEJ) as a DNA repair mechanism [15], and
cleaved phage/plasmid DNA is usually degraded rather
than repaired [16, 17]. In eukaryotes NHEJ enables effi-
cient genome editing by effectively repairing cleaved
DNA. However, this efficient repair mechanism makes
CRISPR-Cas9-mediated virus resistance more prone to
evolving mutant viruses. We detected numerous CRISPR-
edited viruses whose sequence suggests that dsDNA repli-
cative forms of these viruses have been repaired by NHEJ
post-cleavage. Repaired viral genomes have been detected
previously in two earlier studies in stable transgenic plants
[2, 3], as well as in a study with a viral-vector-delivered
CRISPR-Cas9 system in model plants [4] and in studies
aimed at engineering virus resistance in mammalian sys-
tems [18, 19]. The evolution of stable CRISPR-Cas9
cleavage-resistant viruses in plants has been hypothesized
in this journal previously [6], and we now provide con-
firmation of this in a crop plant. One additional consider-
ation in experiments to engineer virus resistance in
eukaryotes is the monitoring period, which in this study
was twice as long as in previous studies [2, 3]. We first de-
tected ACMV-AC2 H54Q at 8 wpi, suggesting that evolu-
tion of resistant viruses may occur later in the infection
process.
Our follow-up experiment in the model plant N.
benthamiana revealed that the replication of the mutant
Table 1 Virus infection results










3 weeks Wild-type – 5/9 55.5 2 0
Cas9 154 0/5 60 1.4 0
155 4/6 66.6 1.7 0
Cas9+sgRNA 92 1/8 12.5 2 0
111 5/5 100 2.8 0
114 6/6 100 2.3 0
118 3/5 60 1.3 0
120 1/9 11.1 1 0
130 1/7 14.3 3 0
139 0/5 0 0 0
8 weeks Wild-type – 6/9 67 1.8 0
Cas9 154 3/5 60 2.3 0
155 6/6 100 2.2 0
Cas9+sgRNA 92 8/8 100 1.9 0
111 5/5 100 2.6 0
114 6/6 100 1.8 0
118 4/5 80 1.7 5.2
120 7/9 78 1.7 0
130 6/7 86 2.5 2.2
139 1/5 20 3 1.6
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virus detected in the CRISPR transgenics was dependent
on the presence of the wild-type virus. This observation
suggests that the mutant virus requires the AC2 and
AC3 proteins expressed by the wild-type virus. In N.
benthamiana plants, the mutant virus also accumulated
to a much lower degree compared to cassava CRISPR
transgenics. This can be explained by the fact that the
wild-type N. benthamiana plants are unable to select for
editing-resistant viruses. Thus, our results indicate that
the activity of the CRISPR system at low efficiency (as
observed in the cassava transgenics) is sufficient to per-
mit the accumulation of CRISPR-resistant mutant vi-
ruses at higher abundances than they would in plants
not expressing the abovementioned CRISPR system.
Conclusions
We found that using CRISPR-Cas9 with a single sgRNA
in cassava resulted in the emergence of a
CRISPR-resistant virus, with a conserved mutation
across three independent transgenic lines. We caution
that CRISPR-induced virus evolution could have import-
ant implications for field studies using CRISPR-Cas9 to
engineer plant virus immunity. The ability of CRISPR
systems to trigger the evolution of new viruses would
also impact the regulatory mechanisms available for
testing and releasing such plants. While regulation of
CRISPR-Cas9-edited, but not transgenic, plants has been
clarified in the US, Japan and the EU, the regulation of
transgenic plants constitutively expressing Cas9 has not
yet been considered [20]. We expect that such plants
will likely proceed under existing biosafety regulations
governing other genetically modified organisms (GMOs).
However, our results point to a novel environmental
containment consideration for regulating the release of
plants constitutively expressing Cas9 and sgRNAs target-
ing a virus. We highly recommend sequencing the virus
population in on-going studies utilizing CRISPR-Cas9 to
engineer virus immunity in plants and animals. We also
recommend testing whether using more efficient ver-
sions of Cas9, targeting multiple virus genes, or using
paired Cas9-nickases to delete larger portions of the
viral genome can delay the emergence of resistant vi-
ruses without enhancing recombination frequencies,
which can participate in the emergence of hypervirulent
geminivirus isolates [8, 21].
Our findings lead us to conclude that strategies to use
CRISPR-Cas9 to engineer virus resistance should be op-
timized to reduce the emergence of editing-resistant vi-
ruses. While the editing-resistant virus in our study is
not independently infectious, this mutant may also be an
Fig. 2 Evaluation of CRISPR/Cas9 expressing transgenics for geminivirus resistance. a Infection rates of cassava mosaic disease symptoms on agro-
inoculated plants monitored weekly over an 8-week period. A minimum of five independent replicates per transgenic lines were infected. b Virus
levels in symptomatic plant samples at 3 and c 8 weeks post infection (wpi). Levels were measured on three replicated pools of symptomatic
leaves from a minimum of five individual plants per line. (ns = no statistical significance observed using Dunn’s multiple comparisons test).
d, e %identity of each virus sequence per line, measured against the reference sequence, across a 100-nt window surrounding the sgRNA site
and across almost the entire viral genome respectively
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Fig. 3 Deep sequencing of CRISPR-edited viruses in cassava transgenics. a Analysis of virus sequences from infected plants at 8 weeks post infection.
Each horizontal line represents a 90-nt window for each individual virus sequence. Peaks represent edits and are scaled to the %mismatch value of
each base pair (see “Methods” for calculation) in a pairwise global alignment with the reference virus sequence. The sgRNA target is indicated by a
shaded red rectangle and a dark line represents the putative cut-site. b The number of instances of each substitution event in the AC2
protein detected in all the plant lines at 8 wpi. Green bars indicate amino acid substitutions in the sgRNA target region. c Distribution of
ACMV-AC2 (H54Q) virus variant in different host plant lines. Percentage values represent the proportion of edited viruses in each line
which contain the conserved CRISPR-induced mutation. d Alignment of some AC2 (H54Q) virus sequences with the sgRNA1 sequence
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intermediate step towards the development of a truly
pathogenic novel virus. One important feature of the
CRISPR system in bacterial cells is its ability to adapt to
invading DNA/RNA species. Further investigation into
the mechanisms that underlie foreign DNA recognition
and spacer acquisition by CRISPR systems in prokary-
otes may finally result in the engineering of adaptive im-
munity to viruses in plants. In the meantime, the
implementation of technologies with the potential to
speed up virus evolution should be carefully assessed as
they pose significant biosafety risks.
Methods
Plasmid cloning
The GoldenGate/MoClo system [22] was used to con-
struct binary vectors for plant transformation. Level 1
plasmids bearing 35S promoter-driven hptII (selectable
marker) and plant codon-optimized cas9-GFP genes were
described in a previous study [23]. T7 promoter-driven
sgRNA cassettes for in vitro expression were chemically
synthesized (Thermo Fisher) and blunt end cloned into a
pJET1.2 vector (Thermo Fisher). The U6 promoter-driven
sgRNA1 gene was chemically synthesized and directly
cloned into a GoldenGate level 1 vector. Level 1 vectors
carrying the hptII, cas9-GFP, and sgRNA1 genes were
cloned into a level 2 vector via a one-pot reaction to pro-
duce binary vectors containing the hptII and cas9 expres-
sion cassettes as well as vectors containing the hptII, cas9,
and sgRNA1 expression cassettes.
sgRNA design
sgRNAs targeting the ACMV DNA A were designed using
two parameters, cleavage efficiency and potential
off-targets. Only sgRNAs with at least two seed sequence
mismatches against the entire 750-Mb cassava genome
were selected. First, high-efficiency sgRNAs were obtained
using published software from the Broad Institute, MIT
[12]. The mismatch search included screening potential
sgRNA targets in the cassava reference genome v6.1
(https://phytozome.jgi.doe.gov) with either the canonical
NGG and non-canonical NAG protospacer-associated
motifs (PAMs) for SpCas9. This yielded only 10 sgRNA
designs (out of a total of 305 possible sgRNAs) meeting
the off-target screening criteria, of which we selected the
best six based on efficiency scores and target loca-
tions. These six sgRNAs (Additional file 1: Figure
S1a) were further tested for effectiveness using an in
vitro cleavage assay with purified Cas9/sgRNA com-
plexes to cleave full-length AMCV amplicons (Add-
itional file 1: Figure S1b). We selected sgRNA1 for
stable expression in transgenic cassava because it had
the best predicted efficiency and performed well in
the in vitro cleavage assay.
In vitro transcription
T7::sgRNA expression cassettes were amplified from
their respective pJET1.2 host vectors using primers listed
in Additional file 1: Table S3. One microgram of
gel-purified linear DNA was used as a template in an in
vitro transcription reaction using 100 U of T7 RNA
Polymerase (EP0111, Thermo Fisher), 0.1 U inorganic
pyrophosphatase (EF0221, Thermo Fisher), 40 U Ribo-
Lock RNase Inhibitor (EO0381, Thermo Fisher), and 10
mM NTP mix (R0481, Thermo Fisher) in 1× T7 RNA
Polymerase buffer for 16 h at 37 °C. Transcribed sgRNAs
were purified by phenol - chloroform extraction.
In vitro Cas9 cleavage assay
The in vitro Cas9 cleavage assay was performed accord-
ing to a previously published protocol [24]. ACMV tem-
plates for cleavage were purified via PCR amplification
from total DNA extracts of infected WT plant tissue
using primers listed in Additional file 1: Table S3. The
purified GFP-tagged Cas9 endonuclease was kindly pro-
vided by Prof Martin Jinek (University of Zurich). Two
hundred and fifty nanograms of ACMV template DNA
was digested with 1 μM each of purified sgRNA and
Cas9 protein. Digestion reactions were stopped at 15, 60,
and 105 min. The in vitro cleavage assay to test resist-
ance to the Cas9-sgRNA1 complex was similarly per-
formed using a 409 synthetic dsDNA template
(Additional file 1: Data S2) designed from the
ACMV-AC2 H54Q sequence.
Plant transformation and growth conditions
We generated cassava transgenic lines expressing the
Cas9 protein together with sgRNA1 (referred to as Cas9
+sgRNA1 lines) as well as control lines expressing only
the Cas9 protein (referred to as Cas9 lines) using an estab-
lished Agrobacterium tumefaciens-mediated transform-
ation protocol [25]. Twenty transgenic cassava lines were
characterized for T-DNA copy number (Additional file 1:
Figure S7) and expression of the full-length, 180-kDa
GFP-tagged, plant codon-optimized Cas9 protein was
verified via Western blotting (Additional file 1: Figure S8).
The selected lines expressed both the Cas9 and sgRNA
transgenes at varying levels (Additional file 1: Figure
S1c,d).
In vitro transformed cassava plantlets were grown
at 28 °C in a 16-h photoperiod and sub-cultured at
4-week intervals in CBM media (1× Murashige-Skoog
medium, 2% sucrose, 2 μM copper sulfate, 0.3% gel-
rite, pH 5.8). Thirty-day-old plantlets were transferred
to soil and grown in glasshouse conditions (14 h
photoperiod, 60% relative humidity, day/night temper-
atures, 26 °C/17 °C).
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Southern blotting for T-DNA integration analysis
Total DNA was extracted from leaves harvested from
4-week-old in vitro grown plants using a modified CTAB
(cetyl trimethylammonium bromide) protocol [26]. The
same leaf samples were used for Western blots and reverse
transcription-quantitative PCR (RT-qPCR) analysis. Ten
micrograms of total DNA was restriction digested with 20
U of HindIII (Thermo Fisher) in an overnight reaction. The
digested DNA was separated on a 0.8% agarose-TAE gel
and transferred overnight onto a positively charged nylon
membrane (Roti-Nylon Plus, Carl Roth). A 700-bp probe
against the hptII gene was PCR amplified from the binary
vector and labeled with [α-32P] dCTP using the
Prime-A-Gene kit (Promega). The nylon membrane was
treated with PerfectHyb Plus Hybridization Buffer (Sig-
ma-Aldrich) for 30min followed by hybridization together
with the radio-labeled probe. Blots were developed using a
Typhoon FLA 7500 imaging system (GE Healthcare Life
Sciences).
Western blotting
Crude protein extracts were prepared by incubating
ground leaf tissue in 5% SDS, 125mM Tris-HCL (pH 6.8),
15% glycerol buffer with 1× EDTA-free Complete Protease
Inhibitor (Roche) for 20min at room temperature. Sam-
ples were centrifuged at 4 °C for 10min to clear debris.
Fifty micrograms of total protein extract was electropho-
resed (after a 1:1 dilution with a bromophenol blue solu-
tion) on a pre-cast Novex 4–20% Tris-Glycine Midi gel
(Thermo Fisher) and transferred to a PVDF membrane
(Carl Roth) using a TransBlot Cell (Bio-Rad) system ac-
cording to the manufacturer’s instructions. Membranes
were blocked using 5% milk and 1× Tris buffered saline,
0.1% Tween20 (1XTBS-T) solution for 1 h at room
temperature. The blocked membrane was incubated in a
primary blotting solution (1XTBS-T) with SpCas9 mono-
clonal (mouse) antibody (Diagenode) at a 1:2500 dilution
and a polyclonal Actin (Rabbit) antibody (Agrisera) at a
1:1000 dilution for 1 h at room temperature. After three
5-min washes with 1XTBS-T, the membrane was incu-
bated with a secondary blotting solution containing IRDye
800CW Goat anti-Mouse IgG and IRDye 680RD Goat
anti-Rabbit IgG antibodies at a 1:5000 dilution each. Blots
were imaged using the LICOR Odyssey CLx fluorescence
imaging system. A PageRuler Prestained protein ladder
(Thermo Fisher) was used for size estimation.
Reverse transcription-quantitative PCR
1.5 μg of total RNA extract from leaf samples was
DNase 1 treated and reverse transcribed with random
hexamer primers using the Revert-Aid First strand
cDNA Synthesis Kit (Thermo Fisher) according to the
manufacturer’s instructions. Quantitative PCR was car-
ried out with the fast SYBR Green dye for 40 cycles on a
Lightcycler 480 instrument (Roche). Relative quanti-
tation was performed using the MePP2A reference
gene using the primers listed in Additional file 1:
Table S3. Results of transgene-expression quantita-
tion using RT-qPCR are presented in Additional file 1:
Figure S1 c, d)
Virus inoculation and symptom monitoring in cassava
Agrobacterium tumefaciens (strain LBA4404) cells carry-
ing infectious clones of ACMV-NOg DNA A and DNA
B [9, 14] were cultured for 48 h at 28 °C in 5 mL YEB
broth (5 g/L tryptone, 1 g/L yeast extract, 5 g/L nutrient
broth, 5 g/L sucrose, 2 mM MgSO4) supplemented with
antibiotics (25 mg/L rifampicin, 100 mg/L streptomycin,
and 50 mg/L kanamycin). Two milliliters of the starter
cultures was then individually added to 200 mL YEB
medium with antibiotics and incubated overnight at 28 °C
to an OD600 of 0.6–1. Cells were pelleted by centrifuging
at 5000×g for 10 min, then re-suspended in 5 mL inocu-
lation medium (10 mM MES pH 5.6, 10 mM MgCl2,
0.25 mM acetosyringone) and incubated for 2 h at room
temperature with shaking. DNA A and DNA B cultures
at an OD600 of 2.0 were mixed in equal proportions
prior to inoculation.
For inoculation, all leaves save the top leaf were re-
moved from 6-week-old cassava plantlets (65 plants in
total). The stem and axillary buds were pricked prior to
dipping the plantlets in Agrobacterium solution for 10 s
and subsequently covered in a Plexiglas box for 3 days.
A minimum of five inoculated plants per line were mon-
itored for symptom incidence and severity over a period
of 8 weeks. Symptoms in the top three leaves were
scored weekly from 3 to 8 weeks post inoculation (wpi)
on a scale of 0–3 as depicted in Additional file 1: Figure
S7. The first emerging leaf from each plant was har-
vested 3 wpi. The top three leaves were harvested from
each plant at 8 wpi.
Virus cloning and inoculation in N. benthamiana
A 582-bp fragment of the ACMV-AC2 H54Q virus
flanked by naturally occurring EcoRI and AflII restric-
tion sites was chemically synthesized (Thermo Fisher).
The original agroclone of the wild-type virus was
digested with EcoRI and AflII, and the newly synthesized
and digested fragment was ligated in place, without any
scarring. The clone was sequence verified by Sanger se-
quencing and electroporated into electrocompetent A.
tumefaciens (strain LBA4404) cells. Agrobacterium cul-
tures were grown and prepared for inoculation as de-
scribed above (with 150 mM acetosyringone). Cells were
infiltrated using a Softject 1-mL syringe in a single fully
expanded leaf. Six N. benthamiana plants per test con-
struct (and three plants per control construct) were infil-
trated and monitored over 4 weeks of growth at 22 °C,
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12 h light. After 4 weeks, the four top-most fully ex-
panded leaves from each plant (not including the infil-
trated leaf ) were harvested for DNA extraction and virus
sequencing.
Quantitation of virus titres
Virus quantitation was performed by RT- qPCR on 10
ng of total DNA extracts using ACMV DNA A-specific
primers and MePP2A genomic DNA reference primers
as listed in Additional file 1: Table S2. Symptomatic
leaves were harvested in three separate pools for each
plant line (in the absence of symptomatic leaves, asymp-
tomatic leaves were used). Three technical replicates
were used per pooled sample. Results are shown in
Fig. 2b, c.
Single molecule real-time sequencing of viral amplicons
Full-length viral amplicons from selected plant lines
were prepared using target-specific primers tailed with
universal sequences (Additional file 1: Table S3) accord-
ing to the protocol provided by Pacific Biosciences Inc.
Equal amounts of each amplicon were used as a tem-
plate in a second PCR using the Barcoded Universal
Primers provided by Pacific Biosciences Inc. (Barcodes
used per sample are listed in Additional file 1: Table S4).
The standard SMRTBell library construction protocol
was used to prepare a pooled, barcoded, sequencing li-
brary. Sequencing was performed using a standard Mag-
Bead loading protocol on a PacBio RSII instrument.
Polymerase reads were processed into barcode separated
subreads by primary analysis on the instrument. The
resulting subreads [27] were processed using a standard
circular consensus sequencing (CCS) analysis using
SMRTPipe with a configuration file specifying a mini-
mum predicted quality of 99.9 and a minimum length of
2600 bp. For the N. benthamiana experiment, an equi-
molar pool of amplified viral DNA from each replicate
plant was pooled to prepare two sequencing pools:
ACMV-AC2 H54Q+ACMV-WT, and ACMV-WT alone.
Each pool was amplified using separate Barcoded Uni-
versal Primers and sequenced as described above.
Sequence analysis
Sequences representing a near full-length region (2692
bp) of the ACMV DNA A genome as well as a 100-bp
region surrounding the sgRNA target site were extracted
from each ROI in order to maintain identical start and
end sequence positions in each viral amplicon sequence
read. Each resulting sequence was pairwise aligned (glo-
bal alignment using NEEDLE parameters) against its
corresponding reference ACMV-NOg DNA A sequence
(GenBank: AJ427910). Pairwise alignment scores were
assigned to each nucleotide as the sequence mismatch
percentage of a 10-nucleotide window surrounding it
[28]. The resulting per-base score (y-axis) along each se-
quence read was plotted using the ggplot and ggjoy
packages in R to produce Fig. 1a and Additional file 1:
Figure S3. Total pairwise identity scores were used to
create Additional file 1: Figure S2d,e. Background mis-
matches resulting from either sequencing errors or viral
variants were found in all lines, including controls. We
also failed to find any conserved edits on viruses infect-
ing Cas9+sgRNA1 lines (and not control lines), indicat-
ing the absence of an off-target on the virus genome
(Additional file 1: Figure S8). This was expected because
the seed sequence of sgRNA1 does not have a close
match to another site on the viral genome.
For the N. benthamiana experiment, SMRT sequen-
cing raw reads were error-corrected using the CCS pipe-
line at a threshold of 99.5 predicted accuracy. Resulting
full-length virus sequences were searched with the mu-
tant sgRNA target site to count the occurrence of mu-
tant viruses.
Additional file
Additional file 1: Table S1. Virus infection results (confirmation
experiment). Table S2. Proportion of ACMV-AC2 H54Q viruses detected
by deep-sequencing in N. benthamiana. Table S3. Primer sequences.
Table S4. Sequencing Barcodes. Figure S1. Analysis of virus sequences
from infected plants at (a) 3 and (b) 8 weeks post infection. Figure S2.
Analysis of viral proteins from edited and control populations obtained
by single molecule amplicon sequencing at 3 weeks post infection.
Figure S3. Analysis of viral proteins from edited and control populations
obtained by single molecule amplicon sequencing at 8 weeks post
infection. Figure S4. In vitro cleavage assay of the ACMV-AC2 H54Q
mutant. Figure S5. Southern blot analysis for number of T-DNA
integration events per plant line. * Figure S6. (a) Western blots for
Cas9-GFP expression. (b) Raw blot images acquired using an Odyssey
CLX imager for anti-Cas9 and anti-Actin probing of protein extracts
from Cas9+sgRNA1 lines. (c) Raw blot images for probing Cas9 lines
protein extracts with anti-Cas9 and anti-Actin antibodies. Figure S7.
Symptom scoring scale. Figure S8. Analysis of full-length virus sequences
from infected plants at 8 weeks post infection. (DOCX 6747 kb)
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